University of Wollongong

Research Online
Australian Institute for Innovative Materials Papers

Australian Institute for Innovative Materials

1-1-2013

Multifunctional conducting fibres with electrically controlled release of
ciprofloxacin
Dorna Esrafilzadeh
University of Wollongong, de256@uowmail.edu.au

Joselito M. Razal
University of Wollongong, jrazal@uow.edu.au

Simon E. Moulton
University of Wollongong, smoulton@uow.edu.au

Elise M. Stewart
University of Wollongong, elises@uow.edu.au

Gordon G. Wallace
University of Wollongong, gwallace@uow.edu.au

Follow this and additional works at: https://ro.uow.edu.au/aiimpapers
Part of the Engineering Commons, and the Physical Sciences and Mathematics Commons

Recommended Citation
Esrafilzadeh, Dorna; Razal, Joselito M.; Moulton, Simon E.; Stewart, Elise M.; and Wallace, Gordon G.,
"Multifunctional conducting fibres with electrically controlled release of ciprofloxacin" (2013). Australian
Institute for Innovative Materials - Papers. 783.
https://ro.uow.edu.au/aiimpapers/783

Research Online is the open access institutional repository for the University of Wollongong. For further information
contact the UOW Library: research-pubs@uow.edu.au

Multifunctional conducting fibres with electrically controlled release of
ciprofloxacin
Abstract
We hereby present a new method of producing coaxial conducting polymer fibres loaded with an
antibiotic drug that can then be subsequently released (or sustained) in response to electrical stimulation.
The method involves wet-spinning of poly(3,4-ethylenedioxythiophene) poly(styrenesulfonate)
(PEDOT:PSS) fibre, which served as the inner core to the electropolymerised outer shell layer of
polypyrrole (Ppy). Ciprofloxacin hydrochloride (Cipro) was selected as the model drug and as the dopant
in the Ppy synthesis. The release of Cipro in phosphate buffered saline (PBS) from the fibres was
controlled by switching the redox state of Ppy.Cipro layer. Released Cipro under passive and stimulated
conditions were tested against Gram positive (Streptococcus pyogenes) and Gram negative (Escherichia
coli) bacteria. Significant inhibition of bacterial growth was observed against both strains tested. These
results confirm that Cipro retains antibacterial properties during fibre fabrication and electrochemically
controlled release. In vitro cytotoxicity testing utilising the neural B35 cell line confirmed the
cytocompatibility of the drug loaded conducting fibres. Electrical conductivity, cytocompatibility and
tuning release profile from this flexible fibre can lead to promising bionic applications such as
neuroprosthetics and localised drug delivery.

Keywords
multifunctional, conducting, ciprofloxacin, fibres, release, electrically, controlled

Disciplines
Engineering | Physical Sciences and Mathematics

Publication Details
Esrafilzadeh, D., Razal, J. M., Moulton, S. E., Stewart, E. M. & Wallace, G. G. (2013). Multifunctional
conducting fibres with electrically controlled release of ciprofloxacin. Journal of Controlled Release, 169
(3), 313-320.

This journal article is available at Research Online: https://ro.uow.edu.au/aiimpapers/783

Multifunctional conducting fibres with electrically controlled release of Ciprofloxacin
Dorna Esrafilzadeh, Joselito M. Razal, Simon E. Moulton, Elise M. Stewart and Gordon
G. Wallace*
ARC Centre of Excellence for Electromaterials Science and
Intelligent Polymer Research Institute, University of Wollongong
Wollongong, NSW 2522, Australia
Abstract
We hereby present a new method of producing coaxial conducting polymer fibres loaded
with an antibiotic drug that can then be subsequently released (or sustained) in response to
electrical
stimulation.
The
method
involves
wet-spinning
of
poly(3,4ethylenedioxythiophene) poly(styrenesulfonate) (PEDOT:PSS) fiber, which served as the
inner core to the electropolymerised outer shell layer of polypyrrole (Ppy). Ciprofloxacin
hydrochloride (Cipro) was selected as the model drug and as the dopant in the Ppy synthesis.
The release of Cipro in phosphate buffer saline (PBS) from the fibres was controlled by
switching the redox state of Ppy.Cipro layer. Released Cipro under passive and stimulated
conditons were tested against Gram positive (Streptococcus pyogenes) and Gram negative
(Escherichia coli) bacteria. Significant inhibition of bacterial growth was observed against
both strains tested. These results confirm that Cipro retains antibacterial properties during
fibre fabrication and electrochemically controlled release. In vitro cytotoxicity testing
utilising the neural B35 cell line confirmed the cytocompatibility of the drug loaded
conducting fibres. Electrical conductivity, cytocompatibility and tuning release profile from
this flexible fibre can lead to promising bionic applications such as neuroprosthetics and
localised drug delivery.
Keywords: Inherently conducting polymer, fibre-spinning, Ciprofloxacin hydrochloride,
drug delivery
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1. Introduction
Advances in the fabrication of neuroprosthetic electrodes have attracted considerable interest
from biomedical researchers [1-5]. These electrodes can be incorporated into a
neuroprosthetic device capable of electrically stimulating cells as well as recording signals
generated by cells [6]. Electrodes can be fabricated into a range of geometries including pads,
cuffs or longitudinal intra-fascicular electrodes [2, 7, 8].
Critical to the successful application of any electrode in vivo is their biocompatibility, stable
conductivity, low impedance, appropriate mechanical properties and flexibility [4]. In
addition, a major factor in implantable device failure is associated with post-surgery infection
[9]; therefore developing an electrode with inherent anti-inflammatory or antibiotic features
is highly attractive [10]. Prevention of infection following the implantation can be addressed
by the incorporation and controlled release of specifically targeted drugs that can be used
singularly, or in combination into neuroprosthetic electrodes [10, 11].
There exists today a wide range of drug delivery formulations such as polymeric
microparticles and implants [12-14], with some structures capable of triggering release in
response to discrete thermal transitions [14, 15], pH [16, 17] or electrical stimuli [18, 19].
Electrically stimulated drug delivery systems have the advantage of tuning the release
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profile by the nature of the stimulation conditions (the current/potential magnitude and
frequency) employed [20]. Consequently, electrical stimulation to affect localised and
controlled release of therapeutic drugs is becoming an attractive option in the treatment of
acute disease or chronic illness [11].
So far, inherently conducting polymers (ICPs) are being utilised in the fabrication of
electrode structures for the primary purpose of recording cellular activities[13], as well as
having the secondary role of responding to electrical stimulation to initiate drug release
[21, 22]. The lower electrochemical impedance of ICPs, compared to metal electrodes, if
combined with an appropriately sized biomolecule/drug, leads to their efficient release
via electrical stimulation[6]. For example, it has been demonstrated that dexamethasone
(DEX) can be effectively released from neural microelectrode surface covered by
poly(3,4-ethylenedioxythiophene) (PEDOT) [5]. The electrically stimulated release of the
neurotrophin NT-3 from polypyrrole has also been reported [20, 23, 24]. Recently,
dexamethasone (an anti-inflammatory drug) and penicillin and streptomycin (antibiotics)
have been incorporated into polypyrrole (Ppy) [25] whilst dexamethasone has also been
incorporated into poly(3,4-ethylenedioxythiophene) (PEDOT) [11] and released using
electrical stimulation.
To date, most of the ICP based drug delivery systems have been limited to
electropolymerised films as stand alone materials or as coatings on other (usually rigid)
substrates [26, 27]. However, the drawbacks associated with the use of ICP films including
their brittleness, inflexibility, need for structural support and competent charge carrier (i.e.
gold mylar) and the delamination from support substrate during redox processes have severly
affected thier use in drug delivery systems [1, 2]. In contrast, ICP fibres can provide selfsupporting three-dimensional, flexible architectures suitable for in vitro and in vivo bionic
applications [1, 2]. ICPs can also allow the incorporation and controlled release of chemical
or biochemical triggers (drugs, growth factors) [26]. Recently, highly conducting
PEDOT:PSS fibres produced by wet-spinning method have been shown to posses stable
electrochemical properties [28]. To the best of our knowledge, ICP microfibre structures have
not been previously used to develop intelligent drug delivery systems.
Here, we present a novel method to produce coaxial ICP fibres wherein electrically controlled
release of the antibiotic ciprofloxacin hydrochloride is achievable. PEDOT:PSS-chitosan
hybrid fibres were fabricated employing a novel wet-spinning strategy involving the
coagulation of PEDOT:PSS using chitosan as the coagulant. The hybrid fibre was
subsequently used as a working electrode for the electropolymerisation of a ciprofloxacin
hydrochloride doped Ppy layer (Ppy.Cipro). The PEDOT:PSS-chitosan core acts as structural
support and electronic conductor to electrochemically switch Ppy.Cipro between reduced and
oxidised states to controllably release (or sustain) Cipro. The bioactivity of the released
antibiotic drug (Cipro) was evaluated in vitro. Furthermore, the cytotoxicity of the fibres and
their components was tested against a neural cell model.
2. Experimental
Materials and methods
2.1. Materials
Poly(3,4-ethylenedioxythiophene) poly(styrenesulfonate) (PEDOT:PSS) pellets were
obtained from Agfa (Orgacon dryTM, Lot A6 0000 AC). Chitosan (CHI) with high molecular
weight (MW) was supplied from Sigma with 75 % rate of deacetylation. Ciprofloxacin
hydrochloride (Cipro) was obtained from MP Biomedical Inc. (Lot No. of 8460H) with
MW=367.84 g mol-1. Ethylene glycol (EG) Reagent Plus ≥ 99% solution was purchased from
2

Sigma-Aldrich (Batch No. of 04397JJ). Pyrrole monomer was obtained from Merck and was
distilled prior to use. Deionised Milli-Q water (18 MΩ cm−1) was used to prepare all aqueous
solutions. The release of ciprofloxacin hydrochloride was measured in Phosphate Buffered
Saline (PBS) solution with pH≈ 7.4 prepared by dissolving standard PBS tablet (Merck,
Germany) in 1 litre water. Glacial acetic acid was purchased from Sigma and diluted to 2.0
wt. %.
2.2. Instrumentation
Wet-spinning of the fibres was performed using custom-made wet-spinning equipment. Fibre
post-spinning treatment was carried out by wetting the fibres with ethylene glycol (EG)
followed by oven drying at 120 °C for 1 hr to improve the conductivity [28-30].
Electropolymerisation of pyrrole monomer was performed galvanostatically in a threeelectrode cell (working, reference and counter electrode) using an eDAQ (Australia)
potentiostat/galvanostat run by eDAQ Chart™ software version 5.2. Electrically stimulated
release of Ciprofloxacin hydrochloride was performed in a three electrode cell. The cyclic
voltammogram of the conducting materials was measured using an eDAQ (Australia)
potentiostat/galvanostat running Echem software version 1.5. The morphology of the fibres
was imaged using field emission scanning electron microscope (FESEM) JEOL7500 at
specific voltage of 5 kV and Optical Leica Microscopy model DMED controlled by Leica
software version (2.4.0 R1). The energy-dispersive X-ray spectroscopy (EDX) was
performed using FESEM JEOL7500 microscope. Raman spectra (laser wavelength used was
623 nm) were obtained using a Jobin Yvon Horiba HR800 Raman spectrometer with Lab
Spec software.
2.3. Wet-spinning of PEDOT:PSS-CHI hybrid fibres
A PEDOT:PSS dispersion (25 mg/ml) in water was homogenised (10,000 rpm for 10 min)
and bath sonicated (1 h) to prepare the spinning solution. The PEDOT:PSS dispersion was
then loaded into a 5 ml syringe with a detachable needle (20 gauge) as the spinneret. The feed
rate of PEDOT:PSS was fixed at 15 ml/h using a syringe pump (KDS-Scientific 100). The
PEDOT:PSS dispersion was injected into the chitosan coagulation bath (1.0 wt. % chitosan
dissolved in 2.0 wt. % acetic acid) to form an ionic cross-linked gel fibre, which was then
washed in an ethanol bath before collection on a spool (Fig. S1). Dried PEDOT:PSS-CHI
fibres were treated with ethylene glycol (EG) followed by heating to 120 °C for 30 min to
increase the conductivity of the hybrid fibres [31].
2.4. Electrochemical characterisation of PEDOT:PSS-CHI fibres
In order to investigate the electrochemical behaviour of hybrid PEDOT:PSS-CHI fibres,
cyclic voltammerty was performed in PBS. Conductivity of the fibres was measured using a
linear four-point probe conductivity cell with uniform 2.3 mm spacing between probes. A
galvanostat current source (Princeton Applied research Model ED402) and digital multimeter
(HP Agilent 34401A) were used to obtain conductivity. Electrochemistry measurements
including cyclic voltammetry of the fibres were performed in a three-electrode cell, using a
potentiostat as described above with software of EChem version 1.5. The electrochemical
impedance spectroscopy (EIS) was carried out in a two-electrode cell in PBS electrolyte
using Gamry Instruments Framework (V.5.5).
2.5. Synthesis of Ppy.Cipro layer on the surface of PEDOT:PSS-CHI fibres
Synthesis of polypyrrole doped with ciprofloxacin hydrochloride (Ppy.Cipro) was performed
galvanostatically in a glass vial containing a platinum mesh (counter electrode), an Ag/AgCl
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reference electrode and a PEDOT:PSS-CHI fibre as the working electrode (Fig. S2). The
length of fibre was 3 cm, however, only 1 cm of the fibre was inserted into the
polymerisation solution. The polymerisation solution contained 0.2 M pyrrole monomer and
50 mM ciprofloxacin hydrochloride in Milli-Q water. Two different current densities (0.5 and
2.0 mA/cm2) with different growth times (10 and 20 min) were applied. All current densities
were normalised by thickness and geometric surface area of the fibres to achieve a similar
thickness of Ppy.cipro layer for each current density and time point. All fibres were washed
in Milli-Q water for 5 min after electropolymerisation to remove any unincorporated Cipro
on the surface of fibres.
2.6. Scanning Electron Microscopy
All images of coaxial fibres were taken using field emission scanning electron microscopy
(FESEM) (JEOL JSM-7500FA). Samples for cross-section imaging were prepared by
breaking a frozen fibre after dipping into liquid nitrogen. Samples were sputter-coated
(EDWARDS Auto 306) with a thin layer of platinum (~3 nm thickness) prior to imaging.The
chemical elements present in the surface and cross section of PEDOT:PSS-CHI fibres were
investigated using Energy-Dispersive X-ray Spectroscopy (EDX). In this case, the presence
of sulphur (PEDOT:PSS) was monitored using FESEM and EDX simultaneously.
2.7. Elemental Analysis.
Elemental analysis for nitrogen (N) and sulphur (S) in the PEDOT:PSS-CHI fibres was
determined using an automatic analyser (Carlo Erba 1106) technique at the Australian
National University (ANU, Canberra). Four different samples were examined including dry
PEDOT:PSS powder, dry chitosan powder, a PEDOT:PSS-CHI film prepared by blending
solutions of PEDOT:PSS and chitosan (1% w/v) at a ratio of 9:1 and PEDOT:PSS-CHI
fibres.
2.8. Mechanical property testing
The tensile properties of the fibres were measured using a Shimadzu EZ-S at a strain rate of
0.5 % min-1. Samples were mounted on aperture cards (1 cm length window) with
commercial super glue and allowed to air dry. Young’s modulus, tensile strength and
breaking strain were calculated and the mean and standard deviation reported for n = 10.
2.9. Ciprofloxacin (Cipro) release measurement
The amount of released Cipro was determined via UV.vis spectroscopy by monitoring the
absorption of Cipro at its λmax 270 nm in PBS. The UV.vis spectra of PBS solutions
containing Cipro at varying concentrations were recorded between 200 nm and 300 nm using
a Shimadzu UV 1601 spectrophotometer in order to construct an absorbance/concentration
calibration curve for sample analysis (Fig. S3-A). No other component of the fibre absorbs at
this wavelength, therefore eliminating any possible interference with compounds other than
Cipro (Fig. S3-B). Loading efficiency of Cipro per 1 cm length of fibre was estimated by
dissolving 1 cm length of fibre in PBS solution. The drug loaded fibre was bath sonicated for
5 days until the fibre completely dissolved and the Ppy.Cipro coating broke down, then the
solution was filtered and the Cipro concentration was obtained by UV.vis spectroscopy. To
monitor the effect of sonication on the absorption properties of Cipro, control solutions of
known concentrations of Cipro in PBS were treated under the same conditions as the fibres.
The release medium was collected by micropipette at specific time points over 3 days and
replaced with the same volume of fresh PBS solution. All cumulative release data are plotted
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as a percentage of (Mt) release relative to the Cipro loading (Mtot). Cipro release was
investigated under passive diffusion and electrical stimulation conditions (applied constant
potential) in different stimulation patterns. In the first one, constant potential (reduced or
oxidised) was applied to fibres during 72h (Fig 4) whilst, in the second pattern, the alternative
constant potential was applied by switching between reduced and oxidised potential every 24
h for 72 h (Fig S8) For electrically stimulated release, a platinum mesh and Ag/AgCl
electrode were utilised as the counter electrode and the reference electrode, respectively
whilst the PEDOT:PSS-CHI-Ppy.Cipro fibre was the working electrode. The release solution
was gently stirred with constant speed during the release experiments to assist diffusion of
Cipro from the surface of the fibres. Fibres with consistent lengths and thicknesses were
chosen as test samples.
2.10. Antibacterial activity of released Ciprofloxacin
The activity of the Ciprofloxacin hydrochloride released from the fibres was tested against
both Gram-negative Escherichia coli (JM109) and Gram-positive Streptococcus pyogenes
(NS5448). Bacterial lawns were prepared by firstly inoculating 5 ml of Luria-Bertani (LB)
medium or Todd Hewitt (TH) broth with E. coli or S. pyogenes respectively for overnight
incubation at 37 °C. This culture was then used to inoculate a 10 ml culture which was grown
to mid-log phase (OD600 0.6-0.8; determined using an Ultrospec10 spectrophotometer). This
culture was then diluted 1/5 in sterile 0.9 % (w/v) NaCl in Milli-Q and 200 μl of this
suspension was spread onto LB or TH agar plates. The bacterial suspension was air dried
prior to application of either fibres or discs. Following fibre production, dried fibres were
prepared in 1cm lengths for antibacterial testing. To test the efficacy of Cipro released from
fibres, lengths were carefully placed onto the surface of the prepared plates which were then
inverted and incubated at 37 °C overnight prior to examination. Both PEDOT:PSS-CHI and
PEDOT:PSS-CHI-Ppy.Cl fibres were tested as controls to ensure no antibacterial activity was
exhibited by other components of the fibres. The bioactivity of Cipro released from the fibres
either passively or under electrical stimulation was also tested. The fibres were placed in 500
μL PBS for 72 h. Release samples were then loaded onto sterile 6 mm discs of Whatman
No.1 filter paper and allowed to air dry at room temperature. The loaded discs were then
carefully placed onto prepared bacterial plates. Discs placed on E. coli lawns were loaded
with 10 μl of release media, and discs placed on S. pyogenes lawns were loaded with 20 μl of
release media to account for the different susceptibilities of the bacterial strains to Cipro.
Control discs were also prepared by preloading with 1 μg of ciprofloxacin hydrochloride for
efficacy comparisons.
2.11. Cytotoxicity testing
The cytotoxicity of PEDOT:PSS-CHI, PEDOT:PSS-CHI-Ppy.Cl and PEDOT:PSS-CHIPpy.Cipro fibres were tested against B35 neuroblastoma cell line (ATCC). Cells were
cultured in DMEM medium supplemented with 10 % (v/v) fetal bovine serum (FBS,
Invitrogen). The composite fibres were aligned on glass slide substrates and 8-well cell
culture chamber was glued onto the substrate to immobilise the fibres at the substrate surface.
The fibre surfaces were sterilised by rinsing in 70 % (v/v) ethanol followed by air drying. The
fibres in each well were coated with Type IV rat tail collagen by exposing the surface to 50
μg/ml collagen prepared in 0.02 % acetic acid solution for 1 h at room temperature. Wells
were then rinsed twice in serum free medium prior to cell seeding at a density of 10,000
cells/cm2. Cells were incubated at 37 °C in a humidified 5 % CO2 environment for 48 h prior
to staining and imaging. Cells were stained for metabolic activity by the addition of Calcein
AM (Invitrogen) to the a final concentration of 1 µg/ml in cell culture media, followed by
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incubation as above for 15 min. Propidium iodide (Invitrogen) was then added to final
concentration of 1 µg/ml and the cells incubated for 5 min at room temperature. Medium was
then removed and replaced with fresh PBS prior to imaging with an AxioImager fitted with a
Mrm AxioCam and images were overlayed using AxioVision Software (Zeiss). An LDH
release assay was also performed to determine the IC50 for Cipro against B35 cells. B35 cells
were seeded at a density of 5,000 cells/well into a 96 well plate. Following 24 h incubation
as described above, cell media was replaced with complete media containing a dilution series
of Cipro starting at the highest concentration of 1 mg/ml. Following 48 h incubation cell
media was collected and assayed for LDH activity using the CytoTox 96® Non-Radioactive
Cytotoxicity Assay (Promega).
3. Results and discussion
3.1. Wet-spinning of PEDOT:PSS-CHI fibres
Polyionic complexation coagulation strategy was employed to wet-spin PEDOT:PSS fibres.
PEDOT:PSS dispersion (25 mg/ml) was injected into a chitosan (CHI) coagulation bath.
Based on the polyionic complexation coagulation strategy [32], the “free” negatively charged
polystyrene sulphonate acid (PSS) groups of PEDOT:PSS can react with positively charged
amino group of chitosan to form a gel fibre. Different concentrations of CHI (from 0.5 to 2
wt. %) were used as the coagulation bath. PEDOT:PSS fibres could not be coagulated at CHI
concentrations less than 1 wt. %. The spinability of PEDOT:PSS fibres improved
significantly at CHI concentrations higher than 1 wt. %. However, the high viscosity of CHI
coagulation bath at concentrations higher than 2 wt. % hindered the spinability of
PEDOT:PSS fibres. In order to minimise the adverse effects of CHI uptake on the electrical
conductivity of the resultant fibre, the minimum CHI concentration (1 wt. %) needed for
effective spinning was chosen as the coagulation bath. The gel fibre was then dehydrated and
washed in an ethanol bath to remove the unreacted CHI from the surface of the fibre. In
contrast to solvent/non-solvent as-spun PEDOT:PSS fibres [28], PEDOT:PSS-CHI fibres
were insoluble and stable in aqueous media (pH ⋍ 7.4) due to present of insoluble chitosan
in pH ⋍ 7.4 and polyionic complexation between chitosan and PEDOT:PSS which facilitates
their use in bionic applications.
The elemental composition of the fibres was evaluated using energy-dispersive X-ray (EDX)
spectroscopy. The EDX spectrum showed sulphur peaks which confirmed the presence of
PEDOT:PSS on the surface of fibre. However, the cross-sectional EDX suggested a hybrid
structure of PEDOT:PSS-CHI fibre where the inner part is rich in PEDOT:PSS and the outer
layer is rich in chitosan (Fig. S4). Elemental analysis was carried out to measure the ratio of
chitosan to PEDOT:PSS in the as-dried hybrid fibre. Based on the percentage of nitrogen
from chitosan and sulphur from PEDOT:PSS in the control samples (Table S1), a calibration
curve was used to determine the ratio of chitosan to PEDOT:PSS. The composition was
calculated to be 3.23% to 96.77%, respectively. Such a low mass ratio of chitosan is
favourable as it shows lower negative impact on the electrical conductivity of the hybrid
fibre.

SEM images of the “as-spun” hybrid fibre is shown in Fig. 1A. The hybrid fibre was dense
and non-porous with a smooth surface and a circular cross section (diameter = 65 ± 7 µm)
upon drying under tension. This circular cross section was obtained over a wide range of
spinning parameters.
The electrochemical behavior of the fibres was investigated using cyclic voltammetry (CV)
using PEDOT:PSS-CHI hybrid fibres as the working electrode in PBS buffer. Ethylene
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glycol (EG) post-treated spun fibres exhibited well defined electrochemical responses
corresponding to oxidation and reduction of the PEDOT backbone (Fig. 1D). The improved
electrochemistry after EG treatment is attributed to a change in the conducting polymer
conformation from a compact coil to an extended coil configuration followed by phase
separation between excess PSS and PEDOT [28-30, 33]. The currents recorded in the CV did
not change noticeably after 100 cycles confirming the electrochemical stability of the fibre
(Fig. S5). The conductivity of EG-treated fibres measured by the four point probe method
was 56 ± 7 S cm-1.

Fig. 1. SEM image of PEDOT:PSS-CHI fibre (A), Cyclic voltammogram of PEDOT:PSSCHI fibre in PBS (pH ~ 7.4) between -1.0 V and +0.8 V at scan rate of 50 mV/s (B). Arrows
indicate the direction of potential scan.
3.2. Electropolymerisation of Ppy.Cipro on PEDOT:PSS-CHI fibre.
The electrical and electrochemical properties of the EG-treated PEDOT:PSS-CHI fibres
demonstrated high electrical conductivity and stable electrochemistry in aqueous media.
Therefore, this fibre was chosen as a micro-dimensional electrode onto which a drug loaded
polypyrrole (Ppy) conducting polymer was electrochemically polymerised. The drug selected
was ciprofloxacin hydrochloride (Cipro), a synthetic chemotherapeutic antibiotic of the
fluoroquinolone drug class [34]. Electropolymerisation of Ppy.Cipro onto the PEDOT:PSSCHI fibre was performed galvanostatically in a monomer solution of 0.2 M pyrrole and 50
mM ciprofloxacin hydrochloride at current densities (0.5 and 2.0 mA/cm2) and
polymerisation times (10 and 20 min). The concentration of monomer was selected on the
basis of previously published work as several studies have been performed with same
concentration of pyrrole monomer [20]. The isoelectric point of ciprofloxacin is 7.4 [35],
therefore Cipro possesses a positive charge at the pH used for the polymerisation (pH ⋍ 4.7).
We propose that the negative chloride ion (Cl-) from the ciprofloxacin hydrochloride acts as
the dopant for the Ppy and the Cipro is physically entrapped as the polymer grows. This
entrapment mechanism has been previously reported by our group for the encapsulation and
controlled release of the positively charged neurotrophin-3 (NT-3) using Ppy [20, 24]. The
total amount of Cipro loaded into a 1cm length (254±13 µg) of fibre was determined to be
42±4 µg/cm. When the Ppy.Cipro polymer was grown on the PEDOT:PSS-CHI fibre, the
oxidation potential generated was between +0.28 to +0.45 V at all investigated current
densities. These oxidation potentials are much lower than the oxidation potential observed
when Ppy.Cipro was synthesised on a gold mylar surface (+0.8V) which allowed us to ensure
the Ppy layer was not over oxidised during polymerisation [26].
SEM images of Ppy.Cipro polymerised on one end of the PEDOT:PSS-CHI fibre is shown in
Fig. 2. The Ppy.Cipro shows a fibrillar morphology, which is significantly different to the
usual “cauliflower” morphology of Ppy reported in the literature even when synthesised at a
higher current density (2.0 mA/cm2 ) with extended polymerisation time (20 min) [20]. We
believe that the PEDOT:PSS-CHI substrate structure facilitates the fibril formation. We
propose that when the PEDOT:PSS-CHI fibre is placed in the monomer solution, the fibre
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swells to form the fine fibril features and as the Ppy.Cipro forms, it locks in this fibril
structure. The mechanical properties of PEDOT:PSS-CHI-Ppy.Cipro fibres were enhanced
compared to their as-spun counterparts. Modulus, strength and breaking strain of
PEDOT:PSS-CHI-Ppy.Cipro fibres, obtained from stress- strain curves, were calculated to be
2.9 ± 0.2 GPa, 128 ±11 MPa, 30.5 ± 4 %, respectively (Fig. 3A). The as-dried EG-treated
PEDOT:PSS-CHI fibres displayed modulus, strength and breaking strain of 2 ± 0.3 GPa, 99 ±
7 MPa, 20.6 ± 1.2 %, respectively.

Fig. 2. SEM images of PEDOT:PSS-CHI fibre after electropolymerisation of the Ppy.Cipro
second layer (A) (arrows show polymerised (black) and uncoated (white) ends), cross section
of Ppy.Cipro end (B) (the white dashed line is included to aid the reader in observing the
Ppy.Cipro layer). The current density used to polymerise the Ppy.Cipro layer was 2mA/cm2
and the polymerisation time was 10 min.
The Ppy.Cipro layer is observed in Fig. 2B as the thin dense layer at the surface of the
PEDOT:PSS-CHI fibre (indicated with a partial dashed line). The thickness of this layer was
determined from the SEM images and the relationship between current density,
polymerisation time and thickness of the Ppy.Cipro layer is shown in Table 1. The thickness
of Ppy.Cipro layer increases as both current density and polymerisation time increase. These
results suggest that the pyrrole monomer does not penetrate into the PEDOT:PSS-CHI fibre
structure due to the non-porous morphology of the fibre and decreased wet ability after EG
treatment.
Table 1. Oxidation potential and thickness of Ppy.Cipro layer as a function of polymerisation
condition. The thickness was determined from SEM images.
Current density Polymerisation time Thickness of Ppy.Cipro layer Oxidation potential
(mA/cm2)
(min)
(µm)
(V)
2.0
20
1.9± 0.1
0.45
2.0
10
1.3± 0.3
0.45
0.5
20
1.4± 0.1
0.33
0.5
10
0.5± 0.1
0.28
Raman spectra were recorded between 800 and 1700 cm−1 to probe the changes that have
occurred at the molecular level after second layer deposition (Fig. 3B). Comparison of band
positions before and after polymerisation confirmed formation of a Ppy.Cipro layer. For the
PEDOT:PSS-CHI fibre, peaks were observed at 1530 cm−1 (C=C stretching), 1426 cm−1
(C=C stretching), 1366 cm−1 (C-C stretching) and 1257 cm−1 (C=C stretching) with these
assignments based on reports by others [28]. Whereas, spectra of the PEDOT:PSS-CHIPpy.Cipro fibre and Ppy.Cipro film (control) both showed a strong sharp peak in 1580 cm-1
(C=C stretching) , a double peak at 1320 and 1380 cm-1 (ring stretching) and peaks in 927
and 1240 cm -1 (C-H out of plane bending) indicative of the oxidised form of Ppy [26].
Transformation of the Raman vibration properties from PEDOT:PSS to Ppy after
electropolymerisation of the second layer confirms formation of Ppy layer onto fibre
substrate. However, changes in Raman spectra depend on the thickness of the Ppy layer and
time of polymerisation. It is worth noting that after polymerisation of longer than 10 min the
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Ppy.Cipro layer was thick enough to avoid penetration of Raman laser into PEDOT:PSS-CHI
layer.

Fig. 3. Stress-strain curves of PEDOT:PSS-CHI and PEDOT:PSS-CHI-Ppy.Cipro fibres (A).
Raman spectra of Ppy.Cipro grown on PEDOT:PSS-CHI fibre (B). Cyclic voltammogram of
PEDOT:PSS-CHI fibre at PBS (pH ⋍ 7.4) between -9.0 V and +0.8V at scan rate of 25 mV/s
before and after electropolymerisation of Ppy.Cipro layer (current density: 2.0 mA/cm2 &
polymerisation time: 10 min). Arrows indicate the direction of potential scan (C) and
electrochemical impedance spectroscopy of wet-spun fibres in comparison to Pt wire (D).
Electrochemical testing of the PEDOT:PSS-CHI fibres (Fig. 3C) shows oxidation and
reduction peaks of at -0.3 V and -0.5 V, respectively. Upon Ppy.Cipro polymerisation, the
oxidation and reduction peaks shifted to +0.2V (oxidation) and -0.1V (reduction) and were
found to be stable when thick Ppy.Cipro layer was achieved (ie. polymerisation time: 10
min). This redox behaviour was similar to that of a Ppy.Cipro film grown on gold mylar,
suggesting these redox peaks were due to the Ppy.Cipro polymer. The oxidation and
reduction peak potential of the Ppy.Cipro is +0.2V and -0.1V respectively. These redox
values are at potentials higher than the oxidation state of the PEDOT:PSS fibre core.(-0.2V)
This provides the possibility to switch between oxidised and reduced state for Ppy.Cipro
layer whilst the PEDOT:PSS layer remains in its oxidised state (conducting state). This is
very important as the PEDOT:PSS core can act as a conduit for charge delivery during
different redox state of drug loaded Ppy.Cipro outer layer.
Fig. 3D showed lower impedance of the PEDOT:PSS-CHI-Ppy.Cipro (~2.8 kΩ/cm2) at 1
kHz (relevant frequency of biological activities) [5] in comparison to platinum wire (~ 10.3
kΩ/cm2). This improved impedance resulted from facilitating penetration of ions which
provide much higher electroactive surface area compared to the Pt wire due to the gel-like
nature of the hybrid fibre. Moreover, the impedance of fibres did not change after
polymerisation of Ppy.Cipro.
3.3. Ciprofloxacin release
The release of the entrapped Cipro from the Ppy.Cipro layer was performed under passive
and electrical stimulation conditions in PBS (pH ⋍ 7.4) at 37 oC in a three electrode cell as
described in the experimental section. A 1 cm length of PEDOT:PSS-CHI-Ppy.Cipro fibre
was placed in PBS with samples taken at various time intervals. Electrically stimulated
release was performed under potentials that induced an oxidised (+0.3 V vs Ag/AgCl) and
reduced (-0.26 V vs Ag/AgCl) state in the Ppy.Cipro layer. These potentials were chosen
from the PEDOT:PSS-CHI-Ppy.Cipro CV shown in Fig. 3C. The passive release of Cipro
showed short term release for the first 8 h followed by a plateau up to 72 h (Fig. 4). These
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results suggest that under passive conditions, Cipro release is dominated by diffusion of nearsurface trapped Cipro. According to the Raman data (Fig. 3B) and high electrical
conductivity of the fibres, the Ppy.Cipro layer is in its conducting state; therefore Ppy tends
to keep its dopant to balance the charge along the polymer backbone to maintain neutral
charge. As the interaction between dopant and polymer comes from electrostatic forces,
passive Cipro release is predominantly the result of drug that is near the surface or loosely
trapped within the layer.
The stimulated release profiles of Cipro from the Ppy.Cipro layer of the PEDOT:PSS-CHIPpy.Cipro fibre are shown in Fig. 4. When the PEDOT:PSS-CHI-Ppy.Cipro fibre is
electrically stimulated, so that the Ppy.Cipro layer is in the oxidised state, the release profile
is very similar to the passive release. The main difference is that in the oxidised state, the
amount of Cipro release has decreased. When a reducing potential is applied to the
PEDOT:PSS-CHI-Ppy.Cipro fibre, longer term sustained release up to 72 h is observed with
approximately 2 times higher concentration of released drug compared to the passive mode.

Fig. 4. Cumulative release profile of Cipro from PEDOT:PSS-CHI-Ppy.Cipro fibres in
different conducting states up to 72 h. The percentage of drug amount (Mt) released relative
to drug loading (Mtot) from fibres. The release experiments were carried out in PBS (pH ⋍
7.4) at 37 oC. Error bars indicate the standard error of the mean (n = 3).
By reducing Ppy.Cipro, an excess negative charge is placed along the polymer backbone, in
order to balance this charge the polymer can either release its negatively charged Cl- dopant
or incorporate cations from the media it is residing in. We have previously shown that Clions are very mobile and are readily expelled upon Ppy electrochemical reduction [36]. As
the dopant is expelled, so is the drug that was physically entrapped during synthesis as
reported before for NT-3 delivery [24]. It has previously been shown that the dopant plays an
important role in determining the extent of release of the entrapped drug [37]. In the oxidised
state around 20 % less Cipro is released in comparison to passive during 72 h. When the
Ppy.Cipro is further oxidised, the polymer posses a positive charge and therefore the Cldopant is retained within the Ppy.Cipro layer. It is likely that the positive charge is balanced
by uptake of negative ions from the PBS solution. However, from Fig. 4 it is clear that upon
oxidation Cipro release is observed, albeit not to the same degree as when in the passive or
reduced state. In addition, the release experiments have been carried out by switching
between reduced and oxidised potential of Ppy.Cipro layer and shown the capability of fibres
to tune release profile in different redox state of conducting polymer (Fig. S8). The control of
release demonstrated here based on charge application highlights the versatility of our fibres
for drug delivery systems. The mechanism for Cipro release is proposed to involve
electrostatic interactions as the application of electrical stimulation protocol varied the
amount of Cipro release. However, both the ionic and hydrophobic properties of polypyrrole
have been shown to vary upon application of electrical stimulus. The expansion and
contraction (actuation) [26] of polypyrrole is also a well-documented property of polypyrrole
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upon oxidation and reduction and these processes may be involved in the release of Cipro. As
all of these properties change simultaneously it is not possible to separate them to determine
which process is the dominant factor driving this release.
3.4. In vitro antibacterial efficacy
The previous section clearly demonstrates that it is possible to incorporate and release Cipro
from the coaxial fibre in a controlled manner. However, it is important to evaluate whether
the Cipro maintains its antibacterial properties during the fabrication process. The formation
of a zone of inhibition (ZOI) within a lawn of bacteria was used to evaluate the efficacy of
released Ciprofloxacin. A ZOI represents inhibition of the growth of an organism within a
designated zone corresponding to the presence of an active substance. In this study, the ZOI
of Cipro was determined for representative Gram-positive and Gram-negative bacteria.
Firstly, the drug loaded and control fibres were applied to lawns of each bacterial strain. A
ZOI was observed surrounding the drug loaded fibres (Fig. 5A & 5C) placed on lawns of
each bacterial strain, but not surrounding the underlying PEDOT:PSS fibre, nor the Ppy
coated Cl-doped fibres. These results confirm that the inhibition of bacterial growth was
solely due to the presence of ciprofloxacin in these fibres. The absence of a ZOI surrounding
the control fibres (PEDOT:PSS-CHI and PEDOT:PSS-CHI-Ppy.Cl) shows that the
components of these fibres do not display any antibacterial effect. The inhibition of bacterial
growth indicates that the associated processing steps required to prepare these fibres do not
adversely affect the bioactivity of the ciprofloxacin under passive release conditions.
Moreover, the amount of drug loaded and subsequently released from the fibre under passive
conditions was sufficient to diffuse through the agar media to affect bacterial growth.
Secondly, the effect of the method of Cipro release from the fibres on its efficacy was
investigated (Fig. 5B & 5D). Cipro-containing media collected after 72 h of cumulative
release was loaded onto bacterial lawns via paper discs. The release medium obtained
following application of electrical stimulation, at both oxidising and reducing potential,
resulted in maintained antibacterial activity, which indicates that electrical stimulation did not
disrupt drug biological activity. This study importantly confirms that Cipro maintains its
bioactivity against both Gram-positive and Gram-negative bacteria during loading via
electrochemical polymerisation and the subsequent electrically stimulated release.

Fig. 5. Zone of inhibition (ZOI) of three different fibres (A and C) and drug release media (B
and D) against S. pyogenes strain (A and B) and E. coli (C and D). (1: PEDOT:PSS-CHIPpy.Cl), ( 2: PEDOT:PSS-CHI-Ppy.Cipro), (3: PEDOT:PSS-CHI), (i: 1µg Cipro), (ii: drug
release in reduced state), (iii: drug release in oxidised state), (iv: drug release in passive
state). Each sample was repeated 3 times.
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Moreover, zones of inhibition (ZOI) obtained using 72 h cumulative release samples against
E. coli and S. pyogenes correlated well with the trend of cumulative release profiles in
passive, reduced and oxidised states of the fibres (Table 2).
Table 2. Zone of inhibition resulting following application of volumes of release medium
obtained under different conditions onto lawns of bacteria via paper discs. Averages of three
independent experiments are shown with standard errors.
Zone of Inhibition (mm)
Samples
Mt/Mtot (%)a
E. coli
S. pyogenes
Reduced

88.0 ±14.0

26.6±0.9

14.3±0.3

Passive

47.1±1.2

27.3±0.3

14.0±1.0

Oxidised

36.5±0.5

22.7±2.8

12.0±1.2

1 µg

31.3±0.6
15.0±0 0
NA
a.
The percentage of Cipro released was determined from the release profiles presented in
Fig. 4.
3.5. Cell growth studies
Previous studies have shown that a concentration less than 150 µg/ml ciprofloxacin
hydrochloride had no adverse effect on proliferation and differentiation of a variety of cell
types including primary cultures of astrocytes and primary fibroblast cell lines [38, 39]. The
cytotoxicity of our fibres was tested in the presence of B35 neuroblastoma cells since, the
fibres are assumed to utilise for neural stimulation with controlled Cipro release. An LDH
release assay was performed in the presence of a dilution series of Cipro and the results
showed Cipro concentrations ≤ 125 μg/ml demonstrated any toxicity against B35
neuroblastoma cells. In addition, Cipro concentrations ≥ 250 μg/ml showed toxicity against
B35 neuroblastoma cells (Fig. 6D). The presence of metabolically active cells in the presence
of drug-loaded fibres was examined using Calcein AM, whereby the production of a green
fluorescent product indicates living, viable cells. A counter stain (propidium iodide) was also
used to indicate the presence of membrane compromised cells, indicated by red fluorescence.
Following 72 h incubation, the cells surrounding the fibres were observed to show green
fluorescence indicating them to be metabolically active with minimal presence of membrane
compromised cells (Fig. 6A-C), similar to control glass substrates (data not shown). These
results indicate the cytocompatibility of our fibres and in addition, show that the dosage of
Cipro released is not high enough to cause cell mortality.

Fig. 6. B35 neural cells cultured on PEDOT:PSS-CHI (A), PEDOT:PSS-CHI-Ppy.Cl (B) and
PEDOT:PSS-CHI-Ppy.Cipro (C) fibres over a period of 72 h (scale bar 800 µm). Calcein
AM/PI staining renders metabolically active and membrane compromised cells bright
fluorescent green and red respectively. The graph indicates the results of an LDH release
12

cytotoxicity assay on the effects of a dilution series of Cipro against B35 cells after 48h
incubation. (D)
4. Conclusions
We have demonstrated a novel approach to produce new conducting polymer-based hybrid
fibre that can be utilised as a micro-electrode for drug delivery applications. The controlled
release of ciprofloxacin hydrochloride was achieved by electrical stimulation of a second
conducting polymer layer. The antibacterial efficacy of the incorporated and released
ciprofloxacin was confirmed against Gram-positive and Gram-negative bacteria indicating
the stability of the antibiotic properties of the drug during processing and release method. In
addition, neural cell culture study on the fibres showed B35 neural cells were not adversely
affected by the presence of the fibres, nor any released products from the fibres.
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